Rett Syndrome Genetic Medicines Summit 2023
We are at a pivotal moment in drug development where the first genetic medicines have entered the clinic and the possibility of achieving cures for Rett is tangible.
In mid September 2023 the Rett Syndrome Research Trust hosted a pioneering meeting, the Rett Syndrome Genetic Medicines Summit. The first meeting of its kind to be organized with biopharmaceutical companies front and center, the Summit gathered basic science, pre-clinical, clinical, and regulatory experts to foster discussion, refine expectations, and identify best practices to expedite genetic medicine development. Our expectations are that the information shared at the meeting and beyond will be a rising tide that lifts all boats and will move us closer to a future without Rett.
Read Summit Press Release.
Summit Program Book
RSRT invited 130 scientists and clinicians from 20 academic institutions, 43 biopharmaceutical companies, NIH and FDA to participate at the Summit via presentations, panel discussions and poster session.
Featured Speakers
Sponsors
